R. Mcintosh, S. Rogers, and L. Lim, Natural History of Central Retinal Vein Occlusion: An Evidence-Based Systematic Review, Ophthalmology, vol.117, issue.6, pp.1113-1136, 2010.
DOI : 10.1016/j.ophtha.2010.01.060

T. Wong and I. Scott, Retinal-Vein Occlusion, New England Journal of Medicine, vol.363, issue.22, pp.2135-2179, 2010.
DOI : 10.1056/NEJMcp1003934
URL : https://hal.archives-ouvertes.fr/hal-00567049

C. Pournaras, E. Rungger-brandle, and C. Riva, Regulation of retinal blood flow in health and disease, Progress in Retinal and Eye Research, vol.27, issue.3, pp.284-330, 2008.
DOI : 10.1016/j.preteyeres.2008.02.002

H. Noma, H. Funatsu, and T. Mimura, Role of soluble vascular endothelial growth factor receptor-2 in macular oedema with central retinal vein occlusion, British Journal of Ophthalmology, vol.95, issue.6, pp.788-92, 2011.
DOI : 10.1136/bjo.2010.192468

D. Boyer, J. Heier, and D. Brown, Vascular Endothelial Growth Factor Trap-Eye for Macular Edema Secondary to Central Retinal Vein Occlusion, Ophthalmology, vol.119, issue.5
DOI : 10.1016/j.ophtha.2012.01.042

D. Brown, P. Campochiaro, and R. Singh, Ranibizumab for Macular Edema following Central Retinal Vein Occlusion, Ophthalmology, vol.117, issue.6, pp.1124-1157, 2010.
DOI : 10.1016/j.ophtha.2010.02.022

D. Brown, J. Heier, and W. Clark, Intravitreal Aflibercept Injection for Macular Edema Secondary to Central Retinal Vein Occlusion: 1-Year Results From the Phase 3 COPERNICUS Study, American Journal of Ophthalmology, vol.155, issue.3, pp.429-466, 2013.
DOI : 10.1016/j.ajo.2012.09.026

. Mis-en-forme, Français (France) Mis en forme : Français (France) Page 19 of 28

P. Campochiaro, D. Brown, and C. Awh, Sustained Benefits from Ranibizumab for Macular Edema following Central Retinal Vein Occlusion: Twelve-Month Outcomes of a Phase III Study, Ophthalmology, vol.118, issue.10, pp.2041-2050, 2011.
DOI : 10.1016/j.ophtha.2011.02.038

F. Holz, J. Roider, and Y. Ogura, VEGF Trap-Eye for macular oedema secondary to central retinal vein occlusion: 6-month results of the phase III GALILEO study, British Journal of Ophthalmology, vol.97, issue.3, pp.278-84, 2013.
DOI : 10.1136/bjophthalmol-2012-301504

N. Papadopoulos, J. Martin, and Q. Ruan, Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab, Angiogenesis, vol.28, issue.281
DOI : 10.1007/s10456-011-9249-6

J. Heier, D. Brown, and V. Chong, Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration, Ophthalmology, vol.119, issue.12, pp.2537-2585, 2012.
DOI : 10.1016/j.ophtha.2012.09.006

J. Heier, P. Campochiaro, and L. Yau, Ranibizumab for Macular Edema Due to Retinal Vein Occlusions, Ophthalmology, vol.119, issue.4, pp.802-811, 2012.
DOI : 10.1016/j.ophtha.2011.12.005
URL : http://doi.org/10.1016/j.ophtha.2011.12.005